BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

91 related articles for article (PubMed ID: 2836964)

  • 1. A cytotoxic human-human hybridoma antibody (TrH6) specific for HLA-DRw52.
    Kolstad A; Hansen T; Hannestad K
    Tissue Antigens; 1988 Feb; 31(2):90-7. PubMed ID: 2836964
    [TBL] [Abstract][Full Text] [Related]  

  • 2. Monoclonal antibody to a supertypic determinant associated with HLA-DRw52.
    Eiermann TH; Krause S; Wölpl A; Ballas M; Goldmann SF
    Hybridoma; 1989 Aug; 8(4):467-74. PubMed ID: 2476377
    [TBL] [Abstract][Full Text] [Related]  

  • 3. A human-human hybridoma (Tr7E2) producing cytotoxic antibody to HLA-DQw1.
    Hansen T; Kolstad A; Mathisen G; Hannestad K
    Hum Immunol; 1987 Dec; 20(4):307-20. PubMed ID: 2449413
    [TBL] [Abstract][Full Text] [Related]  

  • 4. Serological biochemical and functional characterisation of three different HLA-DR monoclonal antibodies derived from C57BL6 mice.
    Sachs JA; Fernandez N; Kurpisz M; Okoye R; Ogilvie J; Awad J; Labeta M; Festenstein H
    Tissue Antigens; 1986 Oct; 28(4):199-207. PubMed ID: 2949394
    [TBL] [Abstract][Full Text] [Related]  

  • 5. Structural comparison of the genes of two HLA-DR supertypic groups: the loci encoding DRw52 and DRw53 are not truly allelic.
    Gorski J; Rollini P; Mach B
    Immunogenetics; 1987; 25(6):397-402. PubMed ID: 3596674
    [TBL] [Abstract][Full Text] [Related]  

  • 6. Production of monoclonal human antibody to HLA-DR5 (DRw11) by mouse/human heterohybridomas.
    Hancock RJ; Martin A; Laundy GJ; Smythe J; Roberts I; Cooke H; Pera S; Bowerman P; Bradley BA
    Hum Immunol; 1988 Jun; 22(2):135-42. PubMed ID: 3262098
    [TBL] [Abstract][Full Text] [Related]  

  • 7. A human hybridoma monoclonal antibody (TrJ11) recognizing a new HLA-DR epitope shared by DR4, DR8, DR11, and DRB1*1303.
    Ge J; Bratlie A; Hannestad K
    Hum Immunol; 1995 Jan; 42(1):27-34. PubMed ID: 7538497
    [TBL] [Abstract][Full Text] [Related]  

  • 8. Complexity of the supertypic HLA-DRw53 specificity: two distinct epitopes differentially expressed on one or all of the DR beta-chains depending on the HLA-DR allotype.
    Knowles RW; Flomenberg N; Horibe K; Winchester R; Radka SF; Dupont B
    J Immunol; 1986 Oct; 137(8):2618-26. PubMed ID: 2428870
    [TBL] [Abstract][Full Text] [Related]  

  • 9. Differential expression of DRw52-like determinants detected by monoclonal antibodies.
    Koning F; Giphart M; Termijtelen A; Bruning H
    Scand J Immunol; 1987 Feb; 25(2):127-31. PubMed ID: 2434986
    [TBL] [Abstract][Full Text] [Related]  

  • 10. Functional polymorphism of the HLA-DR beta III chain.
    Sheehy MJ; Rowe JR; Koning F; Jorgensen L
    Hum Immunol; 1988 Jan; 21(1):49-61. PubMed ID: 2452815
    [TBL] [Abstract][Full Text] [Related]  

  • 11. Mapping of an HLA-DRw52-associated determinant on DR beta 1 molecules.
    Ballas M; Eiermann TH; Wölpl A; Goldmann SF
    Tissue Antigens; 1990 Nov; 36(5):187-93. PubMed ID: 1710076
    [TBL] [Abstract][Full Text] [Related]  

  • 12. A human monoclonal antibody to an HLA-DRw53 (MT3)-like epitope on class II antigens.
    Kosinski S; Hämmerling U; Yang SY
    Tissue Antigens; 1986 Sep; 28(3):150-62. PubMed ID: 2431513
    [TBL] [Abstract][Full Text] [Related]  

  • 13. A human-human hybridoma antibody (TrB12) defining subgroups of HLA-DQw1 and -DQw3.
    Kolstad A; Hansen T; Hannestad K
    Hum Immunol; 1987 Nov; 20(3):219-31. PubMed ID: 2830209
    [TBL] [Abstract][Full Text] [Related]  

  • 14. Variants of HLA-DRw52 defined by T lymphocyte clones.
    Mickelson EM; Masewicz SA; Cotner T; Hansen JA
    Hum Immunol; 1988 Aug; 22(4):263-74. PubMed ID: 2459089
    [TBL] [Abstract][Full Text] [Related]  

  • 15. Two cytotoxic human-human hybridoma antibodies to HLA: TrAH10 (anti A3.1) and TrAG2 (anti B7, Bw42).
    Hansen T; Bratlie A; Johansen B; Hannestad K
    Tissue Antigens; 1989 May; 33(5):520-30. PubMed ID: 2552610
    [TBL] [Abstract][Full Text] [Related]  

  • 16. Cultured human fetal astrocytes can be induced by interferon-gamma to express HLA-DR.
    Pulver M; Carrel S; Mach JP; de Tribolet N
    J Neuroimmunol; 1987 Mar; 14(2):123-33. PubMed ID: 3102554
    [TBL] [Abstract][Full Text] [Related]  

  • 17. Production of a cytotoxic human monoclonal antibody with specificity for HLA-DR4 and -DRw10 by cells derived from a highly sensitized kidney recipient.
    Yendle JE; Bowerman PD; Yousaf K; Roberts IM; Cohen B; Barber L; Lechler R; Hancock RJ; Bradley BA
    Hum Immunol; 1990 Mar; 27(3):167-81. PubMed ID: 1971267
    [TBL] [Abstract][Full Text] [Related]  

  • 18. Serologic subtyping of HLA-DR8 by means of the cytotoxic human monoclonal antibody 5643.
    Viken HD; Thoresen AB; Knutsen I; Thorsby E; Hansen T
    Hum Immunol; 1995 Jul; 43(3):200-6. PubMed ID: 7558937
    [TBL] [Abstract][Full Text] [Related]  

  • 19. A cytotoxic human-human hybridoma antibody (TrC7) specific for HLA-A29.
    Kolstad A; Bratlie A; Hannestad K
    Tissue Antigens; 1989 May; 33(5):542-5. PubMed ID: 2552611
    [TBL] [Abstract][Full Text] [Related]  

  • 20. Production of two human hybridomas secreting antibodies to HLA-DRw11 and--DRw8+w12 specificities.
    Pistillo MP; Mazzoleni O; Kun L; Falco M; Tazzari PL; Ferrara GB
    Hum Immunol; 1991 Jun; 31(2):86-93. PubMed ID: 1712351
    [TBL] [Abstract][Full Text] [Related]  

    [Next]    [New Search]
    of 5.